Home › Non-Hodgkin Lymphoma › Colorado › Denver
Non-Hodgkin Lymphoma clinical trials in Denver, CO
14 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute ( Site 7000), Denver
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RecruitingPhase 1
- Colorado Blood Cancer Institute (Sarah Cannon), Denver
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Colorado Blood Cancer Institute, Denver
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- and 1 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Atlanta, GA18 studies
- Chicago, IL18 studies
- Milwaukee, WI18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer29 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma27 studies
- Colorectal Cancer23 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Pancreatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.